Latest Market Positioning News

Montaka Global Extension Fund has announced a distribution of 11.10 cents per unit for the half-year ending December 2024, alongside details of its Distribution Reinvestment Plan and tax component estimates.

TMK Energy has successfully initiated gas flows from three new pilot wells at its Gurvantes XXXV Project, doubling total field production and advancing toward critical desorption pressures expected by mid-2025.

Element 25 has obtained key regulatory approval from WA's DEMIRS for its Butcherbird Expansion Project, paving the way for a twelve-year production run at 1.1 million tonnes per annum of manganese concentrate. The final hurdle remains the Works Approval, expected imminently.

Calix Limited has extended its Share Purchase Plan closing date to January 31, 2025, offering eligible shareholders more time to invest up to $30,000 each. The company may close the plan early if subscriptions exceed $5 million, signaling strong investor interest in its decarbonisation technology.

Premier Investments reveals a steady sales performance despite ongoing cost-of-living challenges, while preparing for a strategic merger with Myer.

Myer reports flat comparable sales and a slight dip in total sales for the 22 weeks to December 2024, while reaffirming support for its transformative merger with Premier Investments' Apparel Brands.

Pointerra has won a US$2 million contract extension from the US Department of Energy to expand its hurricane impact analysis program, leveraging its Pointerra3D digital twin technology to enhance electric grid resilience across North America.

4DMedical has landed a paid pilot contract with the US Department of Defense to deploy its CT:VQ™ lung imaging technology on active-duty personnel, marking a significant step before FDA submission and spotlighting a billion-dollar market opportunity.

Macmahon Holdings has landed a $463 million mining services contract for the Awak Mas gold project in Indonesia, reinforcing its order book and maintaining its FY25 earnings guidance.

EBR Systems Inc. has responded to ASX's price query, denying any undisclosed information behind recent trading spikes and confirming compliance with listing rules. The company also flagged an upcoming FDA inspection announcement.